El CNIC en el Congreso Europeo de Cardiología 2026

El Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) tendrá una destacada presencia en el Congreso de la Sociedad Europea de Cardiología (ESC Congress 2026) con una intensa agenda científica que incluye la presentación de ensayos clínicos de referencia, investigaciones básicas y traslacionales, documentos de consenso europeos, conferencias magistrales, mesas redondas, sesiones clínicas y presidencias de sesión.

Consulta aquí una muestra de la destacada participación del CNIC:

Viernes, 28 de agosto

• 09.15

• 09:19 h

Sesión: Non-conventional risk factors for cardiovascular disease and how to deal with them
Depression and psychosocial adversity: from mechanism to manageable risk factor (Héctor Bueno)

• 10:45 h

Sesión: Clinical Cases: Non-bacterial endocarditis: complex management decisions illustrated through cases
Moderador: Carlos Nicolás Pérez García.

• 11:00 h

Sesión: Building the next-generation care models in cardio-oncology

Clonal haematopoiesis as a new driver of cardiovascular risk. (José Javier Fuster )

• 11:30 h

Sesión: Beyond the guidelines: closing outcome gaps in cardiovascular care in ethnically diverse populations
Cardiovascular care for women in different parts of the world: challenges and solutions (María Rubini Giménez)

• 12:30 h

Sesión: Macrophage biology and inflammation in cardiovascular disease (Abstract Session)

HDL-associated phosphatidylserine modulates the myeloid compartment and protects from atherosclerosis (Aurora Bernal)

Sábado, 29 de agosto

• 08:30 h

Sesión: Automated decision-making and new forms of choice: are machine learning and generative models in medicine support or risk tools? (Special Session)
Acute cardiovascular care: triage support, risk prediction, and workflow optimisation in emergency settings.( María Rubini Giménez)

• 08:45.

Symposium: Cardiovascular prevention in 2026: from novel tools to societal impact Imaging and subclinical atherosclerosis: enabling precision prevention (Valentin Fuster)

• 09:00

Sesión: REACT - Prevalence of silent atherosclerosis across adult life Speaker: Henning Bundgaard (Rigshospitalet - Copenhagen University Hospital - Copenhagen, Denmark)

Discussant review - REACT Speaker: Isabel Goncalves (Lund University - Malmo, Sweden)

Panel discussion - REACT

• 11:00 h

Sesión: The floor is yours: bring your questions on hormonal replacement therapy and cardiovascular health.

Moderadora:  María Rubini Giménez.

• 13.45

Sesión: Cutting-edge science in dilated cardiomyopathy 

Moderador: Pablo García-Pavía.

• 14:30 h

Sesión: Clinical Cases: Cases of prosthetic valve endocarditis: learning from experience.

Moderador: Carlos Nicolás Pérez García.

Sábado, 30 de agosto

• 08:15 h

Sesión: Illustrative cases of cardiovascular disease in women (Clinical Cases)

Moderadora: María Rubini Giménez.

• 12:00 h

Sesión: Young Investigator Award Session in Cardiovascular Disease in Women

Moderadora: María Rubini Giménez.

• 12.30

Session: Fireside Chat: fireside with the legends

Fireside Chat: fireside with the legends (Valentin Fuster)

• 13:45  

Sesión: Preventing heart failure

State-of-the-art lecture on preventing heart failure. (Borja Ibáñez)

13:45

Sesión: Late-Breaking Clinical Science: cardiac amyloidosis

Efficacy and safety of transthyretin gene silencer eplontersen in patients with transthyretin amyloid cardiomyopathy receiving stabiliser therapy in the CARDIO-TTRansform trial (Pablo García Pavía)

• 16.15

Session: Cardiovascular prevention in children and adolescents

Tools for primordial prevention of cardiovascular disease (Valentin Fuster)

• 17:15 h

Sesión: Ischaemia-reperfusion injury: new biological mechanisms of repair

Moderador: Carlos Galán (CNIC)

Domingo, 31 de agosto

• 11:11 h

Sesión: Made Easy Series – Solving the well-being crisis in healthcare professionals
How to build work-life integration (María Rubini Giménez)

• 11:15

Sesión: Great Debate: no more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction

No more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction: pro: (Borja Ibáñez)

• 13:15 h

Sesión: Improving understanding of disease in dilated cardiomyopathy (Moderated ePosters)

Moderador : Enrique Lara-Pezzi (CNIC)

José Javier Fuster ESC Outscience Achievement Award (confirmar fecha)